2012 MERS outbreak

Middle East Respiratory Syndrome (MERS) Outbreak of 2012

The Middle East Respiratory Syndrome (MERS) outbreak of 2012 was the first recorded emergence of the MERS-CoV virus, a novel coronavirus that was identified in September 2012. This outbreak primarily affected countries in the Middle East, with the majority of cases reported in Saudi Arabia. MERS-CoV is a zoonotic virus, meaning it is transmitted from animals to humans, with camels suspected to be a major reservoir host facilitating transmission to humans.

Background

Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused by the coronavirus known as MERS-CoV. The virus was first reported in Saudi Arabia in 2012 after it was isolated from a man who died from a severe respiratory infection. Subsequent investigations revealed additional cases, indicating an outbreak.

Transmission

The exact mode of transmission of MERS-CoV to humans remains unclear, but it is believed to involve direct or indirect contact with infected dromedary camels, a common domestic animal in the Middle East. Human-to-human transmission has been documented, particularly in healthcare settings, emphasizing the need for stringent infection control measures.

Symptoms and Diagnosis

Symptoms of MERS-CoV infection range from mild or asymptomatic to severe acute respiratory illness and death. Common symptoms include fever, cough, and shortness of breath. Severe cases can lead to pneumonia and kidney failure. Diagnosis involves laboratory testing, primarily real-time polymerase chain reaction (RT-PCR) to detect viral RNA.

Epidemiology

The 2012 MERS outbreak marked the first appearance of the virus in humans. Cases were predominantly reported in the Middle East, with Saudi Arabia being the epicenter. However, travel-associated cases were reported in other countries, highlighting the potential for global spread. The World Health Organization (WHO) played a crucial role in coordinating international response efforts and surveillance.

Prevention and Treatment

There is no specific vaccine or antiviral treatment currently available for MERS-CoV. Prevention strategies focus on general hygiene measures, avoiding close contact with sick individuals, and specific precautions when dealing with camels. Treatment is supportive and based on the patient's clinical condition.

Impact

The 2012 MERS outbreak had significant implications for public health, highlighting the potential for novel coronaviruses to emerge and cause severe disease in humans. It underscored the importance of global surveillance, rapid information sharing, and collaboration in responding to infectious disease threats.

See Also

• Coronavirus diseases
• Severe Acute Respiratory Syndrome (SARS)
• Zoonosis
• Epidemiology of viral diseases

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian